The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 22.1%

Tuesday, May 8, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 8, 2018 /PRNewswire/ -- Stem Cell Therapies, Tissue Engineered Products, Gene TherapiesReport DetailsRead

the full report: https://www.reportlinker.com/p04928836 The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 22.1% in the first half of the forecast period. Stem cell therapies accounted for the majority of the
revenue in the market with an estimated market share of 56.0% in 2017.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new report you find 306-page report you will receive 109 tables and 67 figures – all unavailable elsewhere.The 306-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand new report today you stay better informed and ready to act.Report Scope• Global Translational Regenerative Medicine market forecasts from 2018-2028Global Translational Regenerative Medicine submarket forecasts from 2018-2028 covering:• Stem Cell Therapies• Tissue Engineered Products• Gene TherapiesThis study discusses the late-state clinical trials and pipeline as well as market drivers and restraints of each submarket.Translational Regenerative Medicine regional market forecasts from 2018-2028, covering:United StatesEuropeAsia-Pacific• Rest of the WorldForecasts from 2018-2028 of the leading products in the Global Translational Regenerative Medicine market:• Osteocel Plus• Trinity ELITE• TEMCELL /Prochymal• Apligraf• Dermagraft• Epifix• ReCell• Neovasculgen• Glybera (alipogene tiparvovec)• IMLYGIC (talimogene laherparepvec)Assessment of the leading companies in the Global Translational Regenerative Medicine market:• Alphatec Spine• Anterogen• Athersys• Avita Medical• AxoGen• Medipost• Mesoblast• NuVasive• Ocata Therapeutics• Organogenesis• Pharmicell• Regenerys• TiGenix• UniQure• Vericel Corporation• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.• SWOT and Porter's Five Force analysis of the translational regenerative medicine marketRead the full report: https://www.reportlinker.com/p04928836 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-translational-regenerative-medicine-market-is-estimated-to-grow-at-a-cagr-of-22-1-300642840.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store